Psychiatrist-St. Louis (1099)-Greenbrook

Neuronetics, Inc.; St. Louis (MO); On-site; USD 165,000 - 248,000; Part time

Benefits offered by this job

1099 flexible part-time schedule

No nights, weekends or on-call

Competitive compensation

TMS certification & training provided

Collaborative clinical support team

Growth in interventional psychiatry

Job summary

Greenbrook Mental Wellness Centers, a subsidiary of Neuronetics, Inc., seeks a Board Certified or Board Eligible Psychiatrist to provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments and support the Spravato program in St. Louis, MO.

This flexible part-time, 1099 role offers no nights, weekends, or on-call duties, with competitive compensation and TMS certification and training provided. Join a collaborative team dedicated to treating depression and related conditions.

Qualifications

• MD or DO degree and medical licensure in Missouri or ability to obtain.
• Board certified or board eligible at time of application.
• DEA registration or ability to obtain.

Responsibilities

• Provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments.
• Support the Spravato/esketamine program in St. Louis, MO.
• Collaborate with clinical and operational teams to ensure quality care.
• Maintain regulatory compliance and patient safety in all activities.

Skills

Interventional psychiatry

TMS therapy knowledge

Education

MD/DO

Job description

Greenbrook Mental Wellness Centers, a subsidiary of Neuronetics, Inc., is seeking a Board Certified or Board Eligible Psychiatrist to provide onsite oversight of Transcranial Magnetic Stimulation (TMS) treatments and support the growth of our Spravato® (esketamine) program in St. Louis, MO.

Why Join Us?

• Flexible part-time schedule (1099)
• No nights, weekends, or on-call responsibilities
• Competitive compensation
• TMS certification and training provided
• Opportunity to expand your expertise in interventional psychiatry
• Collaborative clinical and operational support team
• Make a meaningful impact on patients with treatment-resistant depression and other mental health disorders

Qualifications

• MD or DO
• Board Certified or Board Eligible
• Active Missouri medical license (or ability to obtain)
• DEA registration (or ability to obtain)

About Greenbrook

As a leading provider of FDA-cleared, non-invasive therapies for Major Depressive Disorder (MDD) and related conditions, Greenbrook has delivered over 1.3 million treatments to 40,000+ patients. Our mission is to transform mental health care and improve lives through innovative solutions.

Depression affects more than 16 million Americans. At Greenbrook, we’re changing the way it’s treated—and you can be part of that change.

Learn more:

• https://youtu.be/yrr-wlFftT0
• https://www.greenbrooktms.com/patient-stories
• https://www.greenbrookproviders.com

GBSP25